Practical consensus recommendations regarding the use of hormonal therapy in metastatic breast cancer

Senthil Rajappa, J Bajpai, M Basade, M Ganvir, C Goswami, A Murali, AK Rathi, V Kaushal, S Jain, Purvish M Parikh, S Aggarwal

South Asian Journal of Cancer 2018 7(2):137-141

Metastatic breast cancer (MBC) is cancer that has spread from the breast to another part of the body or has come back in another distant location. Treatment options for MBC depend on several factors. One of these factors is the levels of hormone receptors (HRs) in the tumor. Cancers with high levels of HRs, called HR-positive, use the hormones estrogen and progesterone to grow and spread. Hormonal therapy is a type of treatment specifically for HR-positive breast cancer. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations in regards with the use of hormonal therapy and the management of HR-positive MBC for the benefit of community oncologists.

https://ift.tt/2H0JYEA